{"entity":{"type":"insider","cik":"0001458177","url":"/insider/0001458177","json_url":"/insider/0001458177.json","name":"VENROCK HEALTHCARE CAPITAL PARTNERS LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2010-09-22","last":"2018-02-28","span_basis":"filed_date"},"name_variants":[{"name":"VENROCK HEALTHCARE CAPITAL PARTNERS LP","source":"filing","n_filings":8,"first_seen":"2010-09-22","last_seen":"2018-02-28"}],"transactions":[{"id":6878294,"accession":"0001458177-18-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001458177-18-000001","line_url":"/filing/0001458177-18-000001#line-2","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings II, LLC; VHCP Co-Investment Holdings, LLC; VHCP Management II, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; Shah Nimish P; Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.","owner_display_name":"VHCP Co-Investment Holdings II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41331.0,"shares_display":"41,331","price_per_share":0.53,"price_display":"0.53","price_state":"stated","total_value":21905.43,"total_display":"21,905.43","total_whole":"21,905","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-02-28","scope":"insider"},{"id":6878289,"accession":"0001458177-18-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001458177-18-000001","line_url":"/filing/0001458177-18-000001#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings II, LLC; VHCP Co-Investment Holdings, LLC; VHCP Management II, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; Shah Nimish P; Koh Bong Y; Venrock Healthcare Capital Partners II, L.P.","owner_display_name":"VHCP Co-Investment Holdings II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500000.0,"shares_display":"1,500,000","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":825000.0,"total_display":"825,000.00","total_whole":"825,000","shares_owned_after":41331.0,"shares_owned_after_display":"41,331","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-28","scope":"insider"},{"id":6589360,"accession":"0001495384-14-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001495384-14-000004","line_url":"/filing/0001495384-14-000004#line-2","is_derivative":false,"issuer_cik":"0001365618","issuer_name":"Avalanche Biotechnologies, Inc.","issuer_ticker":"AAVL","issuer_name_source":null,"issuer_url":"/issuer/0001365618","owner_cik":null,"owner_name":"VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; Venrock Associates VI, L.P.; Venrock Partners VI, L.P.; Venrock Management VI, LLC; Venrock Partners Management VI, LLC; Hove Anders D; Koh Bong Y; VHCP Co-Investment Holdings, LLC","owner_display_name":"VENROCK HEALTHCARE CAPITAL PARTNERS LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":6800000.0,"total_display":"6,800,000.00","total_whole":"6,800,000","shares_owned_after":2365471.0,"shares_owned_after_display":"2,365,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-08-05","filed_date":"2014-08-07","scope":"insider"},{"id":5422711,"accession":"0001277997-13-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-13-000004","line_url":"/filing/0001277997-13-000004#line-1","is_derivative":false,"issuer_cik":"0001239242","issuer_name":"Anacor Pharmaceuticals, Inc.","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001239242","owner_cik":null,"owner_name":"Venrock Partners Management, LLC; VENROCK ASSOCIATES IV L P; ROBERTS BRYAN E; Venrock Partners, L.P.; VEF Management IV, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC","owner_display_name":"Venrock Partners Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":14.06,"price_display":"14.06","price_state":"stated","total_value":2109000.0,"total_display":"2,109,000.00","total_whole":"2,109,000","shares_owned_after":3575535.0,"shares_owned_after_display":"3,575,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-19","scope":"insider"},{"id":2981451,"accession":"0001277997-12-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-12-000004","line_url":"/filing/0001277997-12-000004#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VENROCK ASSOCIATES IV L P; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; Venrock Partners, L.P.; Venrock Management IV, LLC; VENROCK ENTREPRENEURS FUND IV L P; VHCP Co-Investment Holdings, LLC; VEF Management IV, LLC; Venrock Partners Management, LLC","owner_display_name":"VENROCK ASSOCIATES IV L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19273.0,"shares_display":"19,273","price_per_share":6.3019,"price_display":"6.30","price_state":"stated","total_value":121456.5187,"total_display":"121,456.52","total_whole":"121,457","shares_owned_after":3725535.0,"shares_owned_after_display":"3,725,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-20","filed_date":"2012-09-24","scope":"insider"},{"id":2354014,"accession":"0001277997-12-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-12-000003","line_url":"/filing/0001277997-12-000003#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"Venrock Partners Management, LLC; VENROCK ASSOCIATES IV L P; VEF Management IV, LLC; Venrock Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners, L.P.","owner_display_name":"Venrock Partners Management, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":6.5087,"price_display":"6.51","price_state":"stated","total_value":227804.5,"total_display":"227,804.50","total_whole":"227,805","shares_owned_after":3744808.0,"shares_owned_after_display":"3,744,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-14","filed_date":"2012-09-18","scope":"insider"},{"id":3443881,"accession":"0001277997-12-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001277997-12-000002","line_url":"/filing/0001277997-12-000002#line-2","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VEF Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners Management, LLC; Venrock Partners, L.P.; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC","owner_display_name":"VEF Management IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.5553,"price_display":"6.56","price_state":"stated","total_value":98329.5,"total_display":"98,329.50","total_whole":"98,330","shares_owned_after":3779808.0,"shares_owned_after_display":"3,779,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-13","filed_date":"2012-09-13","scope":"insider"},{"id":3443880,"accession":"0001277997-12-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001277997-12-000002","line_url":"/filing/0001277997-12-000002#line-1","is_derivative":false,"issuer_cik":"0001277994","issuer_name":"Anacor Pharmaceuticals Inc","issuer_ticker":"ANAC","issuer_name_source":null,"issuer_url":"/issuer/0001277994","owner_cik":null,"owner_name":"VEF Management IV, LLC; VHCP Co-Investment Holdings, LLC; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; VENROCK ENTREPRENEURS FUND IV L P; Venrock Partners Management, LLC; Venrock Partners, L.P.; VENROCK ASSOCIATES IV L P; Venrock Management IV, LLC","owner_display_name":"VEF Management IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10177.0,"shares_display":"10,177","price_per_share":6.6427,"price_display":"6.64","price_state":"stated","total_value":67602.7579,"total_display":"67,602.76","total_whole":"67,603","shares_owned_after":3794808.0,"shares_owned_after_display":"3,794,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-09-11","filed_date":"2012-09-13","scope":"insider"},{"id":9106263,"accession":"0001458177-11-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001458177-11-000002","line_url":"/filing/0001458177-11-000002#line-1","is_derivative":false,"issuer_cik":"0001239242","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001239242","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings, LLC; Hove Anders D; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; ROBERTS BRYAN E","owner_display_name":"VHCP Co-Investment Holdings, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75000.0,"shares_display":"75,000","price_per_share":4.9999,"price_display":"5.00","price_state":"stated","total_value":374992.5,"total_display":"374,992.50","total_whole":"374,993","shares_owned_after":5189934.0,"shares_owned_after_display":"5,189,934","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-02","filed_date":"2011-02-04","scope":"insider"},{"id":7186915,"accession":"0001458177-10-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001458177-10-000001","line_url":"/filing/0001458177-10-000001","is_derivative":false,"issuer_cik":"0001239242","issuer_name":"Chelsea Therapeutics International, Ltd.","issuer_ticker":"CHTP","issuer_name_source":null,"issuer_url":"/issuer/0001239242","owner_cik":null,"owner_name":"VHCP Co-Investment Holdings, LLC; Hove Anders D; VENROCK HEALTHCARE CAPITAL PARTNERS LP; VHCP Management, LLC; ROBERTS BRYAN E","owner_display_name":"VHCP Co-Investment Holdings, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99000.0,"shares_display":"99,000","price_per_share":6.2995,"price_display":"6.30","price_state":"stated","total_value":623650.5,"total_display":"623,650.50","total_whole":"623,651","shares_owned_after":3024253.0,"shares_owned_after_display":"3,024,253","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-20","filed_date":"2010-09-22","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"ARCA biopharma, Inc.","url":"/issuer/0000907654","role":"Ten percent owner","n_filings":1,"first_seen":"2018-02-28","last_seen":"2018-02-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Avalanche Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Ten percent owner","n_filings":1,"first_seen":"2014-08-07","last_seen":"2014-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001411158","name":"Anacor Pharmaceuticals, Inc.","url":"/issuer/0001411158","role":"Ten percent owner","n_filings":4,"first_seen":"2012-09-13","last_seen":"2013-11-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001333763","name":"Chelsea Therapeutics International, Ltd.","url":"/issuer/0001333763","role":"Ten percent owner","n_filings":2,"first_seen":"2010-09-22","last_seen":"2011-02-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001458177","retrieved_at":"2026-08-22T12:56:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}